Literature DB >> 8821078

Dopaminergic effects on cognitive performance in patients with Parkinson's disease.

K W Lange1, G M Paul, M Naumann, W Gsell.   

Abstract

A group of twelve patients with idiopathic Parkinson's disease was assessed both on and off L-Dopa medication on a range of tests of cognitive performance. Withdrawal of L-Dopa produced impairments in tests sensitive to frontal lobe dysfunction such as verbal fluency and the Tower of London task. Another test of frontal lobe function, the Wisconsin Card Sorting Test, was not affected in the absence of L-Dopa. Memory functions such as short-term span and verbal paired associate memory were not impaired by L-Dopa withdrawal. The results suggest that some of the cognitive impairments observed in Parkinson's disease, namely frontal lobe deficits, are related to a loss of central dopaminergic function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8821078

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  13 in total

1.  Dopaminergic modulation of memory and affective processing in Parkinson depression.

Authors:  Lee X Blonder; John T Slevin; Richard J Kryscio; Catherine A Martin; Anders H Andersen; Charles D Smith; Frederick A Schmitt
Journal:  Psychiatry Res       Date:  2013-07-06       Impact factor: 3.222

2.  Cognitive function in people with and without freezing of gait in Parkinson's disease.

Authors:  Rosie Morris; Katrijn Smulders; Daniel S Peterson; Martina Mancini; Patricia Carlson-Kuhta; John G Nutt; Fay B Horak
Journal:  NPJ Parkinsons Dis       Date:  2020-05-15

Review 3.  Prefrontal Contributions to Attention and Working Memory.

Authors:  Zahra Bahmani; Kelsey Clark; Yaser Merrikhi; Adrienne Mueller; Warren Pettine; M Isabel Vanegas; Tirin Moore; Behrad Noudoost
Journal:  Curr Top Behav Neurosci       Date:  2019

Review 4.  Management of Parkinson's disease dementia : practical considerations.

Authors:  Arvid Rongve; Dag Aarsland
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

5.  Spatial and object working memory deficits in Parkinson's disease are due to impairment in different underlying processes.

Authors:  Katherine L Possin; J Vincent Filoteo; David D Song; David P Salmon
Journal:  Neuropsychology       Date:  2008-09       Impact factor: 3.295

6.  Kinematic analysis of dopaminergic effects on skilled handwriting movements in Parkinson's disease.

Authors:  O Tucha; L Mecklinger; J Thome; A Reiter; G L Alders; H Sartor; M Naumann; K W Lange
Journal:  J Neural Transm (Vienna)       Date:  2005-08-05       Impact factor: 3.850

7.  Mild cognitive impairment in Parkinson's disease: the challenge and the promise.

Authors:  Hubert H Fernandez; Gregory P Crucian; Michael S Okun; Catherine C Price; Dawn Bowers
Journal:  Neuropsychiatr Dis Treat       Date:  2005-03       Impact factor: 2.570

8.  L-dopa medication in Parkinson's disease restores activity in the motor cortico-striatal loop but does not modify the cognitive network.

Authors:  Thomas Jubault; Laura Monetta; Antonio P Strafella; Anne-Louise Lafontaine; Oury Monchi
Journal:  PLoS One       Date:  2009-07-07       Impact factor: 3.240

9.  Central dopaminergic system and its implications in stress-mediated neurological disorders and gastric ulcers: short review.

Authors:  Naila Rasheed; Abdullah Alghasham
Journal:  Adv Pharmacol Sci       Date:  2012-09-13

10.  An investigation of semantic similarity judgments about action and non-action verbs in Parkinson's disease: implications for the Embodied Cognition Framework.

Authors:  David Kemmerer; Luke Miller; Megan K Macpherson; Jessica Huber; Daniel Tranel
Journal:  Front Hum Neurosci       Date:  2013-04-18       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.